Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Oral diseases and taste sensitivity in patients infected with SARS-CoV-2 and patients with COVID-19 disease (CROSBI ID 731281)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Vidović Juras, Danica ; Brailo, Vlaho ; Lončar Brzak, Božana ; Andabak Rogulj, Ana ; Škrinjar, Ivana ; Verzak, Željko ; Lukšić, Ivica ; Karlović, Zoran ; Burja Monika Oral diseases and taste sensitivity in patients infected with SARS-CoV-2 and patients with COVID-19 disease // EAOM 2021 : program & abstract book. Porto, 2021. str. 139-139

Podaci o odgovornosti

Vidović Juras, Danica ; Brailo, Vlaho ; Lončar Brzak, Božana ; Andabak Rogulj, Ana ; Škrinjar, Ivana ; Verzak, Željko ; Lukšić, Ivica ; Karlović, Zoran ; Burja Monika

engleski

Oral diseases and taste sensitivity in patients infected with SARS-CoV-2 and patients with COVID-19 disease

In the relevant literature, various changes of oral mucosa and taste disorders have been described so far in patients with COVID-19 disease, and there is no data on how specific this is and whether it can be an indicator of the disease. The aim of this study was to test two hypotheses: People infected with the SARS-CoV-2, with or without signs of COVID-19 disease, do not have specific recognizable oral manifestations of the disease. Taste sensitivity disorder may be an early sign of infection or disease. The study involved 145 subjects divided into 3 groups: H (hospitalised patients with SARS-CoV-2 infection), P - post-COVID-19 group (after COVID- 19 disease) and controls (without past or current SARSCoV-2 infection). Oral examinations were performed by specialists in oral medicine/oral pathology, as the most relevant experts in identifying and describing possible oral lesions. Also, data on possible taste disorders were collected from all participants. Results: In 8/50 H-group patients asymptomatic oral candidiasis (different types) was found and in 5/8 it was accompanied with severe hyposalivation. 2/50 H-group patients reported taste disorder (dysgeusia and hypogeusia) which developed parallelly with dry mouth. P-group participants haven't noticed oral diseases during infection, nor they were found in the post-COVID period. 25/49 P-group subjects reported taste sensitivity disorder and/or loss during COVID infection and in 20/49 it was a presenting sign of the disease. In 5/46 controls oral lesions (2 fibromas, oral candidiasis, morsicatio, oral mucosal peeling, fistula) were found. None of the controls reported a taste sensitivity disorder. In conclusion, nor individuals infected with SARS- CoV-19 neither patients with COVID-19 disease have specific or non-specific oral manifestations that could be useful in clinical practice, i.e. that can help identify and possibly predict the course of the disease. Taste sensitivity disorder and/or loss is a possible presenting sign of SARS- CoV-2 infection.

oral diseases ; taste sensitivity ; SARS-CoV-2 ; COVID-19

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

139-139.

2021.

objavljeno

Podaci o matičnoj publikaciji

EAOM 2021 : program & abstract book

Porto:

Podaci o skupu

15th Biennial congress European association of oral medicine

poster

23.09.2021-25.09.2021

Porto, Portugal

Povezanost rada

Dentalna medicina, Javno zdravstvo i zdravstvena zaštita